ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,047Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 520

$2.17M Total Retail Price of All Prescriptions

Rank: 7 out of 520

1,483 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 14,319 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$135 was the average price of a prescription from this provider, compared to $204 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
NAMENDA 1,932 1,903 1 4
DONEPEZIL HCL 1,794 1,741 2 3
GABAPENTIN 1,127 957 3 1
EXELON 1,079 1,049 10 4 10
CARBIDOPA-LEVODOPA 984 954 5 2
PRIMIDONE 557 527 10 6 8
PRAMIPEXOLE DIHYDROCHLORIDE 501 471 10 7 17
ZONISAMIDE 456 371 10 8 36
MECLIZINE HCL 444 393 9 57
CYCLOBENZAPRINE HCL 377 270 R 10 34
ESCITALOPRAM OXALATE 268 263 11 29
ROPINIROLE HCL 243 217 12 12
LYRICA 237 221 13 11
CYMBALTA 236 224 14 14
CLOPIDOGREL 226 213 15 44
TOPIRAMATE 224 122 16 6
QUETIAPINE FUMARATE 211 207 17 42
PLAVIX 201 183 18 49
AZILECT 192 179 19 23
CLONAZEPAM 187 187 20 80
PHENYTOIN SODIUM EXTENDED 177 123 21 24
LAMOTRIGINE 174 123 22 9
STALEVO 100 173 168 10 23 104
MELOXICAM 159 133 24 33
AGGRENOX 131 128 25 46
OXCARBAZEPINE 125 81 26 35
DILANTIN 120 79 27 54
SEROQUEL 118 108 28 77
AMANTADINE 108 95 29 39
LEXAPRO 106 101 30 74
DIVALPROEX SODIUM 102 39 31 38
SERTRALINE HCL 101 97 32 21
AMITRIPTYLINE HCL 100 90 R 33 16
LEVETIRACETAM 97 92 34 5
RIVASTIGMINE 92 92 35 84
CARBIDOPA-LEVODOPA-ENTACAPONE 91 73 36 72
DIVALPROEX SODIUM ER 90 58 37 45
CARBAMAZEPINE 87 49 38 20
FOLIC ACID 82 66 39 87
GALANTAMINE HBR 81 81 40 15
CITALOPRAM HBR 72 60 41 13
RISPERIDONE 72 64 41 47
TEMAZEPAM 65 64 43 87
PROPRANOLOL HCL 65 56 43 40
MIRTAZAPINE 63 63 45 50
IBUPROFEN 59 38 46 65
PHENOBARBITAL 59 49 R 10 46 216
ZOLPIDEM TARTRATE 58 58 48 22
STALEVO 150 56 36 49 139
PAROXETINE HCL 55 48 50 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.